Immune factors influencing ethnic disparities in kidney transplantation outcomes

References

• Wolfe RA, Oji AO, Ettenger RE et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med.341, 1725–1730 (1999).
   PubMed Web of Science ®Google Scholar
• Katznelson S, Gjertson DW, Cecka JM. The effect of race and ethnicity on kidney allograft out come. In: Clinical Transplants 1995. Cecka JM, Terasaki PI (Eds). UCLA Tissue Typing Laboratory, CA, USA, 379–394 (1996).
   Google Scholar
• Isaacs RB, Nock SL, Spencer CE et al. Racial disparities in renal transplant outcomes. Am. J. Kidney Dis.34, 706–712 (1999).
   PubMed Web of Science ®Google Scholar
• Meier-Kriesche HU, Ojo AO, Leichtman AB et al. Effect of mycophenolate mofetil on long-term outcomes in African American renal transplant recipients. J. Am. Soc. Nephrol.11, 2366–2370 (2000).
   PubMed Web of Science ®Google Scholar
• Mizutani K. HLA mismatches and PRA in kidney retransplants. Clin. Transpl.21, 19–27 (2007).
   Google Scholar
• 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999–2008. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI, USA.
   Google Scholar
• Kallich JD, Adams JL, Barton PL, Spritzer KL. Access to cadaveric kidney transplantation. Santa Monica, CA, USA, RAND (1993).
   Google Scholar
• Padiyar A, Augustine JJ, Bodziak KA, Aeder M, Schulak JA, Hricik DE. Influence of African–American ethnicity on acute rejection after early steroid withdrawal in primary kidney transplant recipients. Transplant. Proc.42, 1643–1647 (2010).
   Google Scholar
• Scantlebury V, Gjertson D, Eliaszi M et al. Effect of HLA mismatch in African–Americans. Transplantation65, 586–588 (1998).
   Google Scholar
• Meier-Kriesche HU, Ojo AO, Leichtman AB et al. Interaction of mycophenolate mofetil and HLA matching on renal allograft survival. Transplantation71, 398–401 (2001).
   PubMed Web of Science ®Google Scholar
• Schnitzler MA, Hollenbeak CS, Cohen DS et al. The economic implications of HLA matching in cadaveric renal transplantation. N. Engl. J. Med.341, 1440–1446 (1999).
   Google Scholar
• Meier-Kriesche HU, Scornik JC, Susskind B, Rehman S, Schold JD. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation88, 23–29 (2009).
   Google Scholar
• Young CJ, Gaston RS. Renal transplantation in African–American Americans. N. Engl. J. Med.343, 1545–1552 (2000).
   PubMed Web of Science ®Google Scholar
• Evans RW. Money matters: should ability to pay ever be a consideration in gaining access to transplantation? Transplant. Proc.21, 3419–3423 (1989).
   Google Scholar
• McCormick PA, O’Rourke M, Carey D, Laffoy M. Ability to pay and geographical proximity influence access to liver transplantation even in a system with universal access. Liver Transpl.10, 1422–1427 (2004).
   Google Scholar
• Ayanaian J, Cleary P, Weissman J et al. The effect of patient’s preference on racial differences in access to renal transplantation. N. Engl. J. Med.341, 1661–1669 (1999).
   Google Scholar
• Bach P, Pham H, Schrag D et al. Primary care physicians who treat African–Americans and Whites. N. Engl. J. Med.351, 575–584 (2004).
   PubMed Web of Science ®Google Scholar
• Ozminkowski R, White A, Hassol A et al. What if socioeconomics made no difference: access to cadaver kidney transplant as an example. Med. Care.36, 1398–1406 (1998).
   Google Scholar
• Sequist TD, Narva AS, Stiles SK, Karp SK, Cass A, Ayanian JZ. Access to renal transplantation among American Indians and Hispanics. Am. J. Kidney Dis.44, 344–352 (2005).
   Google Scholar
• Julapalli VR, Kramer JR, El-Serag HB. Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl.11, 1370–1378 (2005).
   PubMedGoogle Scholar
• Weng FL, Reese PP, Mulgankar S, Patel AM. Barriers to lving donor kidney transplantation among black or older transplant candidates. Clin. J. Am. Soc. Nephrol.5, 2338–2347 (2010).
   Google Scholar
• Gaston RS, Hudson SL, Deierhoi MH et al. Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression. Transplantation53, 103–109 (1992).
   PubMed Web of Science ®Google Scholar
• Neylan JF. Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African–American renal allograft recipients. Transplantation64, 1277–1282 (1997).
   PubMed Web of Science ®Google Scholar
• Sanders CE, Curtis JJ, Julian BA et al. Tapering or discontinuing cyclosporine for financial reasons – a single center experience. Am. J. Kidney Dis.21, 9–15 (1993).
   Google Scholar
• Hricik DE, Whalen CC, Lautman J et al. Withdrawal of steroids after renal transplantation – clinical predictors of outcome. Transplantation53, 41–45 (1992).
   PubMed Web of Science ®Google Scholar
• Ahsan N, Hricik D, Matas A, Tomlanovich S, Wilkinson A; for the Steroid Withdrawal Study Group. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil – a prospective randomized study. Transplantation68, 1865–1874 (1999).
   PubMed Web of Science ®Google Scholar
• Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantion60, 225–232 (1995).
   PubMed Web of Science ®Google Scholar
• Podder H, Podbielski J, Hussein I, Katz S, Van Buren C, Kahan BD. Sirolimus improves the two-year outcome of renal allografts in African–American patients. Transplant. Int.14, 135–42 (2001).
   PubMed Web of Science ®Google Scholar
• Lindholm A, Welsh M, Rutzky L, Kahan BD. The adverse impact of high cyclosporine clearance rates on the incidences of acute rejection and graft loss. Transplantation55, 985–993 (1993).
   PubMedGoogle Scholar
• Schroeder TJ, Hariharan S, First MR. Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulations. Transplant. Proc.27, 837–839 (1995).
   PubMed Web of Science ®Google Scholar
• Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation63, 977–983 (1997).
   PubMed Web of Science ®Google Scholar
• Floyd MD, Gervasini G, Masica AL et al. Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in basal an induced metabolism of midazolam in European and African American men and women. Pharmacogenetics13, 595–606 (2003).
   PubMedGoogle Scholar
• Zheng HX, Zeevi A, McCurry K et al. The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients. Transpl. Immunol.14, 37–42 (2005).
   Google Scholar
• Zheng HX, Webber S, Zeevi A et al. Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. Am. J. Transplant.3, 477–483 (2003).
   PubMed Web of Science ®Google Scholar
• Kuehl P, Zhang J, Yin Y et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat. Genet.27, 383–391 (2001).
   PubMed Web of Science ®Google Scholar
• Bain BJ. Ethnic and sex differences in the total and differential white cell count and platelet count. J. Clin. Pathol.49, 664–666 (1996).
   PubMed Web of Science ®Google Scholar
• Freedman DS, Gates L, Flanders WD et al. Black/white differences in leukocyte subpopulations in men. Int. J. Epidemiol.26, 757–764 (1997).
   Google Scholar
• Kerman RH, Floyd M, Van Buren CT, Kahan BD. Improved allograft survival of strong immune responder-high risk recipients with adjuvant antithyocyte globulin therapy. Transplantation30, 450–454 (1980).
   Google Scholar
• Kerman RH, Kimball PM, Van Buren CT, Lewis RM, Kahan BD. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. Transplantation51, 338–342 (1991).
   PubMed Web of Science ®Google Scholar
• Hricik DE, Rodriguez V, Riley J et al. Enzyme linked immunoabsorbent spot assay for interferon-γ independently predicts renal function in kidney transplant recipients. Am. J. Transplant.3, 878–884 (2003).
   PubMed Web of Science ®Google Scholar
• Augustine JJ, Siu D, Clemente M, Schulak JA, Heeger PS, Hricik DE. Pretransplant IFN-γ ELISpots are associated with posttransplant renal function in African American renal transplant recipients. Am. J. Transplant.5, 1971–1975 (2005).
   PubMed Web of Science ®Google Scholar
• Poggio ED, Clemente M, Hricik DE, Heeger PS. Panel of reactive T cells as a measurement of primed cellular alloimmunity in kidney transplant candidates. J. Am. Soc. Nephrol.17, 564–572 (2006).
   PubMed Web of Science ®Google Scholar
• Augustine JJ, Poggio ED, Clemente M et al. Hemodialysis vintage, black ethnicity, and pretransplantation antidonor cellular immunity in kidney transplant recipients. J. Am. Soc. Nephrol.18, 1602–1606 (2007).
   Google Scholar
• Yang Y, Wilson JM. CD40 ligand-dependent T cell activation: requirement of B7–CD28 signaling through CD40. Science273, 1862–1864 (1996).
   PubMed Web of Science ®Google Scholar
• Hutchings A, Purcell WM, Benfield MR. Peripheral blood antigen-presenting cells from African–Americans exhibit increased CD80 and CD 86 expression. Clin. Exp. Immunol.118, 247–252 (1999).
   Google Scholar
• Hutchings A, Purcell WM, Benfield MR. Increased costimulatory responses in African American kidney allograft recipients. Transplantation71, 692–695 (2001).
   Google Scholar
• Inocencio JD, Choi E, Glass DN, Hirsch R. T cell receptor repertoire differences between African Americans and Caucasians associated with polymorphism of the TCRBV3S1 (V β 3.1) gene. J. Immunol.54, 4836–4841 (1995).
   Google Scholar
• Dai Z, Lakkis FG. The role of cyokines, CTLA-4, and costimulation in transplant tolerance and rejection. Curr. Opin. Immunol.11, 504–508 (1999).
   PubMed Web of Science ®Google Scholar
• Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production of IFN-γ correlates with CA repeat polymorphism in the human IFN-γ gene. Eur. J. Immunogenet.26, 1–3 (1999).
   PubMedGoogle Scholar
• Awad MR, El Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-β 1 gene: association with transforming growth factor-β 1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation66, 1014–1020 (1998).
   PubMed Web of Science ®Google Scholar
• Hoffmann SC, Stanley EM, Darrin CE et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation72, 1444–1450 (2001).
   PubMed Web of Science ®Google Scholar
• Sankaran D, Asderakis A, Ashraf S et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int.56, 281–288 (1999).
   PubMed Web of Science ®Google Scholar
• Asderakis A, Sankaran D, Dyer P et al. Association of polymorphisms in the human interferon-γ and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation. Transplantation1, 674–677 (2001).
   Google Scholar
• Turner D, Grant SC, Yonan X et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation64, 776–779 (1997).
   PubMed Web of Science ®Google Scholar
• Holweg CT, Baan CC, Balk AH et al. The transforming growth factor β1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation. Transplantation71, 1463–1467 (2001).
   PubMed Web of Science ®Google Scholar
• Awad MR, Webber S, Boyle G et al. The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. J. Heart. Lung. Transplant.20, 635–630 (2001).
   Google Scholar
• Tambur AR, Ortegel JW, Ben Ari Z et al. Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients. Transplantation71, 1475–1480 (2001).
   Google Scholar
• Miki C, McMaster P, Mayer AD, Iriyarna K, Suzuki H, Buckels JA. Factors predicting perioperative cytokine response in patients undergoing liver transplatnation. Crit. Care Med.28, 351–428 (2000).
   Google Scholar
• Hoffmann SC, Stanley EM, Cox ED et al. Ethnicity greatly influences cytokine polymorphism distribution. Am. J. Transplant.2, 560–567 (2002).
   PubMed Web of Science ®Google Scholar
• Cox ED, Hoffmann SC, DiMercurio BS et al. Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation72, 720–726 (2001).
   PubMed Web of Science ®Google Scholar
• Delaney NL, Esquenazi V, Lucas DP, Zachary AA, Leffell MS. TNF-α, TGF-β, IL-10, IL-6, and INF-γ alleles among African Americans and Cuban Americans. Report of the ASHI Minority Workshops: Part IV. Hum. Immunol.65, 1413–1419 (2004).
   PubMed Web of Science ®Google Scholar
• Van Parijs L, Perez VL, Abbas AK. Mechanisms of peripheral T cell tolerance. Novartis. Found. Symp.33, 5–14 (1998).
   Google Scholar
• Li Y, Li XC, Zheng XX, Wells AD, Turka LA, Strom TB. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat. Med.5, 1298–1302 (1999).
   PubMed Web of Science ®Google Scholar
• Marshall SE, McLaren AJ, Haldar NA, Bunce M, Morris PJ, Welsh KI. The impact of recipient cytokine genotype on acute rejection after renal transplantation. Transplantation70, 1485–1491 (2000).
   PubMed Web of Science ®Google Scholar
• Lowry RP, Konieczny B, Alexander D et al. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice. Transplant. Proc.27, 392–394 (1995).
   Google Scholar
• Mottram PL, Han WR, Purcell LJ, McKenzie IF, Hancock WW. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-γ in long-surviving mouse heart allografts afterbrief CD4-monoclonal antibody therapy. Transplantation59, 559–565 (1995).
   Google Scholar
• Zheng XX, Steele AW, Nickerson PW, Steurer W, Steiger J, Strom TB. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J. Immunol.154, 5590–5600 (1995).
   PubMed Web of Science ®Google Scholar
• Hutchings A, Guay-Woodford L, Thomas JM et al. Association of cytokine single nucleotide polymorphisms with B7 costimulatory molecules in kidney allograft recipients. Pediatr. Transplant.6, 69–77 (2002).
   PubMed Web of Science ®Google Scholar
• McDaniel DO, Barber WH, Nguyan C et al. Combined analysis of cytokine genotype polymorphism and the level of expression with allograft function in African–American renal transplant patients. Transplant. Immun.11, 117–119 (2003).
   Google Scholar
• Suthanthiran M, Li B, Song JO et al. Transforming growth factor β1 hyperexpression in African–American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc. Natl Acad. Sci. USA97(7), 3479–3484 (2000).
   PubMed Web of Science ®Google Scholar
• Thakkinstian A, Dmitrienko S, Gerbase-DeLima M et al. Association between cytokine gene polymorphisms and outcome in renal transplantation: a meta-analysis of individual patient data. Nephrol. Dial. Transplant.23, 3017–3023 (2008).
   PubMed Web of Science ®Google Scholar
• Hancock W, Liqing W, Ye Q et al. Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr. Opin. Immunol.15, 479–486 (2003).
   PubMed Web of Science ®Google Scholar
• Lalor P, Adams DH. Lymphocyte homing to allografts. Transplantation70, 1131–1139 (2000).
   Google Scholar
• DeVries M, Hosiawa KA, Cameron CM et al. The role of chemokines and chemokine receptors in alloantigen-independent and alloantigen-dependent transplantation injury. Semin. Immunol.15, 33–48 (2003).
   Google Scholar
• Rot A. In situ binding assay for studying chemokine interactions with endothelial cells. J. Immunol. Methods273, 63–71 (2003).
   Google Scholar
• Middleton J, Patterson, AM, Garner L et al. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood100(12), 3853–3860 (2002).
   PubMed Web of Science ®Google Scholar
• Fukuma N, Akimitsu N, Hamamoto H et al. A role of the Duffy antigen for the maintenance of plasma chemokine concentrations. Biochem. Biophys. Res. Commun.303, 137–139 (2003).
   PubMedGoogle Scholar
• Dawson T, Lentsch AB, Wang Z et al. Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood96, 1681–1684 (2000).
   PubMedGoogle Scholar
• Peiper S, Wang Z, Kuldeep N et al. The duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of duffy negative individuals who lack the erythrocyte receptor. J. Exp. Med.18, 1311–1317 (1995).
   Google Scholar
• Chaudhuri A, Nielsen S, Eikjaer ML et al. Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of noneyrthroid organs. Blood89, 701–712 (1997).
   PubMed Web of Science ®Google Scholar
• Segerer S, Regele H, Mack M et al. The Duffy antigen receptor for chemokines is upregulated during acute renal transplant rejection and crescentic glomerulonephritis. Kidney Int.58, 1546–1556 (2000).
   PubMed Web of Science ®Google Scholar
• Sergerer S, Regele H, Mack M et al. When renal allografts turn DARC. Transplantation75, 1030–1034 (2003).
   Google Scholar
• Nickel R, Willadsen SA, Friedhoff LR et al. Determination of Duffy genotypes in three populations of African descent using PCR and sequence specific oligonucleotides. Hum. Immunol.60, 738–742 (1999).
   PubMedGoogle Scholar
• Hadley TJ, Peiper SC. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood89, 3077–3091 (1997).
   PubMed Web of Science ®Google Scholar
• Danoff TM, Hallows KR, Burns KL, Brayman KL, Feldman HI. Renal allograft survival in African–Americans: influence of the Duffy Blood Group [abstract]. Transplantation67, S8 (1999).
   Google Scholar
• Douzdjian V, Kukuruga DL, Bajjoka IE, Abouljoud MS. The impact of Duffy blood type on renal allograft survival in African Americans [abstract]. Transplantation69(8), S142 (2000).
   Google Scholar
• Akalin E, Neylan JF. The influence of Duffy blood group on renal allograft outcome in African Americans. Transplantation75, 1496–1500 (2003).
   Google Scholar
• Mange KC, Prak EL, Kamoun M et al. Duffy antigen receptor and genetic susceptibility of African Americans to acute rejection and delayed function. Kidney Int.66, 1187–1192 (2004).
   Google Scholar
• Peiper S, Wang Z, Kuldeep N et al. The duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of duffy negative individuals who lack the erythrocyte receptor. J. Exp. Med.181, 1311–1317 (1995).
   PubMed Web of Science ®Google Scholar
• Pallet N, Thervet E, Alberti C et al. Are African Europeans different from African Americans? Am. J. Transplant.5, 2682–2687 (2005).
   PubMed Web of Science ®Google Scholar
• Young CJ, Gaston RS. Understanding the influence of ethnicity on renal allograft survival. Am. J. Transplant.5, 2603–2604 (2005).
   Google Scholar
• Genovese G, Friedman DJ, Ross MD et al. Association of tripanolytic APOL1 variants with kidney disease in African Americans. Science329, 841–845 (2010).
   PubMed Web of Science ®Google Scholar
• Freedman BI, Kopp JB, Langefeld CD et al. The apolipoprotein L1 (APOL1) gene and diabetic nephropathy in African Americans. J. Am. Soc. Nephrol.21, 1422–1426 (2010).
   PubMed Web of Science ®Google Scholar
• Reeves-Daniel AM, DePalma JA, Bleyer AJ et al. The APOL1 gene and allograft survival in kidney transplantation. Am. J. Transplant DOI: 10.1111/j.1600-6143.2011.03513.x (Epub ahead of print) (2011).
   Google Scholar